James D. Clark - Aug 3, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Stock symbol
CVS
Transactions as of
Aug 3, 2023
Transactions value $
-$1,930,004
Form type
4
Date filed
8/4/2023, 05:41 PM
Previous filing
Apr 4, 2023
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Sale -$197K -2.63K -8.64% $74.79 27.8K Aug 3, 2023 Direct F1
transaction CVS Common Stock Sale -$1.73M -23.1K -83.12% $74.94 4.7K Aug 3, 2023 Direct F2
holding CVS Common Stock (Restricted) 8.88K Aug 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 9.05K Aug 3, 2023 Common Stock 9.05K $78.05 Direct F3
holding CVS Stock Option 7.51K Aug 3, 2023 Common Stock 7.51K $62.21 Direct F4
holding CVS Stock Option 24.2K Aug 3, 2023 Common Stock 24.2K $54.19 Direct F5
holding CVS Stock Option 17.2K Aug 3, 2023 Common Stock 17.2K $58.34 Direct F6, F7
holding CVS Stock Option 12.1K Aug 3, 2023 Common Stock 12.1K $74.30 Direct F8
holding CVS Stock Option 6.76K Aug 3, 2023 Common Stock 6.76K $101.09 Direct F9
holding CVS Stock Option 9.65K Aug 3, 2023 Common Stock 9.65K $74.31 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share.
F2 Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share.
F3 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F4 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F5 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F6 The number of shares subject to the option were calculated using a 30-day average price.
F7 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F9 Option became exercisable in four equal installments, commencing 4/1/2023.
F10 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.